Last Updated on August 29, 2023 by
Alternative to Meds Editorial Team
Medically Reviewed by Dr Samuel Lee MD
Table of Contents:
- Video: Antipsychotics FAQs
- The Clinical Trials — What is Known About the Long-Term Effects of Rexulti?
- What about Rexulti Long-Term Effects in Schizophrenia Trials?
- Rexulti Clinical Trials as an Adjunct to Antidepressant Medications
- Rexulti Long-Term Adverse Events — Summary
- Rexulti Half-life
- What is Known about Rexulti’s Mechanisms of Action?
- Can Holistic Treatment Help Avoid the Long-Term Effects of Rexulti?
- Treatment at Alternative to Meds Center
Since Rexulti is a relatively new antipsychotic drug, the long-term effects of Rexulti are not yet fully understood. For nearly 20 years, Alternative to Meds Center has provided a retreat-style healing experience for anyone looking for relief using much less unpredictable measures.
Often, prescribers turned to Rexulti when other medications did not attain the results that were desired, or simply as a hopeful experiment. Alternative to Meds Center uses a much more measured and practical approach to treatment, without focusing on drugs, to eliminate unwanted symptoms.
Do Your Symptoms Require Rexulti?
Our long history of successful treatment has been documented in independent research which we invite you to review. Below we’ll cover an overview of the long-term effects of Rexulti and also describe the methods used at the center that have led to so much success using holistic treatments to address mental health concerns.
Although it is classified as an antipsychotic drug, one of the common uses of Rexulti is to prescribe it on top of antidepressant medications when the antidepressants that were being used failed to get a positive change in the person. The majority of drug trials on Rexulti have been to study efficacy in treating major depressive disorder. The FDA granted approval for this use when Rexulti first appeared on the market. Notably, much research shows that only a percentage of persons with MDD adequately respond to antidepressant medications, according to a mammoth review of medical literature published in 2015 in the Journal of Psychiatry and Neuroscience.1
The FDA drug label cites a total of two 6-week-long studies combining Rexulti with antidepressant medications in patients who did not respond well to antidepressants alone. About 600 participants were treated with combined Rexulti (at varying dosages) plus an unspecified antidepressant, compared to approximately 400 participants (the study was double-blind) who were given a placebo plus their regular antidepressant medication.7
Increased mortality including risk of stroke, cerebral adverse events, and death in elderly dementia patients
We tailor a treatment program that is highly individualized to fit the needs of the client. That will usually involve 
